Try our Advanced Search for more refined results
Intellectual Property UK
-
June 24, 2025
Gambling Giant Entain Can't Block Italian Rival's 'Sportbet' TM
Sports betting group Entain has failed to halt an Italian competitor's "Sportbet" trademark application, with European Union officials ruling that there is no risk of confusion with its existing "Sportingbet" brand.
-
June 24, 2025
Real-World Views Fair Game In TM Disputes, Top Court Says
Britain's highest court ruled Tuesday that judges can think about how products will look in the real world when weighing trademark infringement claims, but it agreed with a French footwear company that it didn't tread on sports giant Umbro's diamond logo trademark.
-
June 23, 2025
Haribo Group Nixes Monster Energy TMs Over Non-Use
Gummy bear maker Haribo group has convinced European officials to nix two Monster Energy trademarks after the sports drink giant failed to provide any evidence that it had genuinely used the signs to sell a myriad of products in the past five years.
-
June 23, 2025
Staffer Can't Ax Amazon's Defense To Russia Tech Sale Claim
A former Amazon employee on Monday lost his bid to strike out the tech giant's defense to his claims that he was fired for blowing the whistle on alleged sales of its facial recognition technology to Russia.
-
June 23, 2025
Dryrobe Claims Rival's Name Confuses Consumers At TM Trial
Outdoor clothing brand Dryrobe said a rival's use of the name "D-Robe" might lead to consumers confusing it with its own successful brand, on the first day of a trademark dispute trial on Monday.
-
June 23, 2025
Univ. Of Calif., Astellas Defend Cancer Drug IP In Dutch Court
The University of California and Astellas Pharma have persuaded a Dutch court to uphold a patent covering prostate cancer drug Xtandi, marking another win in their fight to keep generic versions off the shelves.
-
June 23, 2025
Teva Voids Novartis' European Patent Over Cancer Drug
An appeals board has stripped Novartis of its European patent over a cancer drug following a challenge from Teva, ruling in a decision published Monday that the treatment isn't inventive.
-
June 20, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen Pogust Goodhead face legal action from mining giant BHP Group, Trainline bring a procurement claim against the Department for Transport, Sworders auction house sue Conservative peer Patricia Rawlings, and Nokia hit with a patents claim by Hisense. Here, Law360 looks at these and other new claims in the U.K.
-
June 20, 2025
AstraZeneca Must Give University More Info In IP Rate Battle
A London judge on Friday ordered AstraZeneca to give the University of Sheffield more information about how the pharma giant sublicensed its patented cancer drug amid the university's claims that AstraZeneca lied to get better rates.
-
June 20, 2025
Reckitt Denies Ex-VP's £1M Claim, Cites Trade Secret Breach
Consumer goods company Reckitt has rejected claims that it owes more than £1 million ($1.4 million) to a former senior executive from Russia, arguing that it fired him ahead of the end of his garden leave because he was working with a bidder for part of its business.
-
June 27, 2025
Hogan Lovells Adds IP Duo In Paris From A&O Shearman
Hogan Lovells has broadened its intellectual property litigation bench in Europe with the hire of two heavyweight intellectual property litigators, who join the firm's Paris office as partners from A&O Shearman.
-
June 20, 2025
BBC Confronts AI Biz Perplexity Over Content Scraping
The BBC said Friday that it has threatened to take legal action against Perplexity, an AI-powered search engine, claiming that the company trained its model on the broadcaster's content.
-
June 20, 2025
Janssen Biotech Loses Patent For Lab-Grown Cells
Janssen Biotech has lost its case at a European Patent Office appellate board to patent its method for treating Type 1 diabetes through lab-grown cells, after the patent appeals board agreed with rival Sanofi that its method lacked the required inventive edge.
-
June 20, 2025
Mathys & Squire Appoints New Chief For Consulting Arm
Intellectual property specialist Mathys & Squire LLP said Friday that it has recruited a senior manager at KPMG Law to lead its consulting arm.
-
June 19, 2025
EPO Rejects Narrow Read Of Patent Claims In Landmark Case
The top appeals board at the European Patent Office has ruled that examiners must always look at the description and drawings when interpreting patents, ditching the approach of assessing a patent's claims in isolation.
-
June 19, 2025
Swedish Court Resurrects BSH IP Battle With Electrolux
Sweden's Svea Court of Appeal has resurrected appliance giant BSH's patent infringement claim against rival Electrolux, following a landmark ruling from the European Union's top court that gives BSH the go-ahead to pursue its claim outside the bloc.
-
June 19, 2025
Dior Beats Hong Kong Co.'s 'Dio' TM
European officials have nixed a Hong Kong firm's trademark application for "Dio," ruling that shoppers might think it was somehow linked to the online "Diorverse" range of French luxury brand Christian Dior.
-
June 19, 2025
Formula One 'Surrenders' Rights To Old EU TM
Formula One has lost one of its iconic F1 trademarks after declaring its "total surrender" to European officials, having failed to provide any evidence that it had used the sign in the past five years amid a rebranding campaign.
-
June 19, 2025
Nestlé's Crunch Crumbles After Fitness Brand Challenge
Nestlé has lost its "Crunch" trademark for a chocolate bar after it left a bid by a British sports nutrition company to nix the mark unchallenged, with officials finding the food giant had not put the mark to good use.
-
June 18, 2025
Cycling Brand's 'Brooks' TM Row Gets Fresh Air In Appeal Win
A bicycle gear company has revived its attempt to block a trademark registration by U.S. rival Brooks Running, having convinced an EU appeals board that its saddlebags are a little too close to athletic bags and backpacks aimed at runners.
-
June 18, 2025
Artist Defends 'Fishrot' Apology Spoof As Free Expression
An Icelandic artist urged a London appellate judge Wednesday to give him a chance to override a decision that he could not successfully defend against a claim from the country's largest seafood company alleging he created a spoof website to publish a false apology over a bribery scandal.
-
June 18, 2025
Standards Org. Halts 'Bluetooth Karaoke Microphone' TM Bid
A Bluetooth standards organization has persuaded European Union officials to block a "Bluetooth Karaoke Microphone" trademark application, proving that consumers could connect the mark to the Bluetooth brand.
-
June 18, 2025
EU Court Affirms Decision To Publicize Pesticide Ingredients
An agrochemical company lost its appeal at a European court on Wednesday to block the European Food Safety Authority from releasing a confidential list of ingredients in one of its pesticides in the interest of public knowledge.
-
June 18, 2025
US Biotech Biz Says Rival's Gene Editing Patent Is Invalid
A U.S. biotech company and two manufacturers have denied they infringed a South Korean rival's gene-editing patent, urging a London court to declare the patent invalid.
-
June 17, 2025
EasyGroup Appeals TM Loss To 'Easy Live' Auction Co.
U.K. venture capital conglomerate easyGroup on Tuesday urged a London appellate court to overturn the rejection of its trademark infringement and revocation case against an online auction services provider, arguing a lower court judge had wrongly disregarded evidence of confusion among consumers.
Expert Analysis
-
Exam Board Ruling Expands Scope Of 'Newcomer Injunctions'
The High Court's recent decision granting AQA Education a digital "newcomer injunction" prevents anonymous internet users from distributing unlawfully obtained exam materials, and extends the scope of such injunctions from issues of trespass to the protection of confidential information, say lawyers at Fieldfisher.
-
Considering The Status Of The US Doctrine Of Patent Misuse
A recent Ninth Circuit decision and a U.K. Court of Appeal decision demonstrate the impact that the U.S. Supreme Court's 2015 decision in Kimble v. Marvel Entertainment has had on the principle that post-patent-expiration royalty payments amount to patent misuse, not only in the U.S. but in English courts as well, say attorneys at Covington.
-
Sky Trademark Ruling Suggests Strategy Tips For Brands
Following the U.K. Supreme Court's SkyKick v. Sky trademark ruling, brand owners should strike a balance between a specification broad enough to meet business requirements but not so broad as to invite unnecessary counterattacks for bad faith, says Josh Charalambous at RPC.
-
Keeping Up With Europe's Pregrant Description Amendments
A recent Technical Board of Appeal decision that there is no legal basis in the European Patent Convention for requiring pregrant description amendments has generated legal uncertainty on this issue, and practitioners should consider deleting unclaimed alternatives, say attorneys at Finnegan.
-
How The UPC, ITC Complement Each Other In Patent Law
Attorneys at Ropes & Gray discuss the similarities and differences between the Unified Patent Court and the International Trade Commission, as well as recent matters litigated in both venues and why parties choose to file at these forums.
-
Rowing Machine IP Loss Waters Down Design Protections
The Intellectual Property Enterprise Court's recent judgment dismissing WaterRower's claim that its wooden rowing machines were works of artistic craftsmanship highlights divergence between U.K. and European Union copyright law, and signals a more stringent approach to protecting designs in a post-Brexit U.K., say lawyers at Finnegan.
-
Takeaways From EU's Draft AI Code Of Practice
The European Union AI Office’s recently published first draft of the General-Purpose AI Code of Practice sheds some welcome light on which Artificial Intelligence Act compliance issues the office finds particularly knotty and, importantly, acknowledges where further guidance will be necessary, say lawyers at Akin.
-
The Rising Tide Of EU Antitrust Enforcement In Pharma
The European Commission’s recent record-breaking €463 million fine of Teva for abusing its dominant position confirms that European Union competition law enforcement in the pharmaceutical sector remains a priority, with infringements drawing serious financial exposure, say lawyers at Cooley.
-
What The Future Of AI In Financial Services Looks Like
Artificial intelligence is rapidly transforming the global financial services industry, with a hybrid model likely to evolve where AI handles routine tasks and humans focus on strategy and decision-making, so financial institutions should work with regulators to establish ethical standards and meet regulatory expectations without stifling innovation, say lawyers at Womble Bond.
-
The EU Design System Changes US Cos. Need To Know About
With a number of major reforms to the European Union's design protection system set to take effect in the first half of 2025, U.S. companies need to stay informed about specific details to maintain effective intellectual property management in the EU market, say lawyers at Finnegan.
-
What New Int'l Treaty Means For Global AI Regulation
Lawyers at Bird & Bird consider how global artificial intelligence regulation will be affected by the first international AI treaty recently signed by the U.S., EU and U.K., as well as its implications for business and several issues that stakeholders should be aware of.
-
HMRC Transfer Pricing Guide A Vital Resource For Businesses
HM Revenue & Customs' recent guidelines on common transfer pricing compliance risks should be required reading for affected businesses in indicating HMRC's expected benchmark for documents and policies, say Tomoko Ikawa and Kapisha Vyas at Simmons & Simmons.
-
Comparing Apples To Oranges In EPO Claim Interpretation
A referral before the Enlarged Board of Appeal could fundamentally change the role that descriptions play in claims interpretation at the European Patent Office, altering best drafting practices for patent applications construed there, say lawyers at Finnegan.
-
Why India May Become A Major Patent Litigation Forum
India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.
-
Takeaways From UPC's Amgen Patent Invalidity Analysis
The Unified Patent Court Central Division's decision in Regeneron v. Amgen to revoke a patent for lack of inventive step is particularly clear in its reasoning and highlights the risks to patentees of the new court's central revocation powers, say Jane Evenson and Caitlin Heard at CMS.